Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NTI Nanotechnology was a privately held Canadian nanotechnology company that developed applied materials solutions spanning health, infrastructure, environment, and industrial use cases. In healthcare-related applications, the company promoted its YZER Health line of anti-viral and anti-bacterial products for textiles, plastics, sanitizers, wipes, masks, gowns, and related protective products using nano colloidal silver formulations. The company appears to have been an operating commercial-stage materials business rather than a drug-development biotech, with no evidence of a therapeutic clinical pipeline. Corporate records indicate that NTI Nanotechnology Corp. was dissolved in Canada on June 28, 2023, so it does not appear to be an active company today. Overall, it is best characterized as a nanomaterials and applied health-products company with limited evidence of formal biopharma R&D activity.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NTI Nanotechnology.